NDC11 70121157302
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 70121-1573-02 | 70121-1573 |
| 70121-1573-2 | 70121-1573 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Physicians EZ Use M-pred | BUPIVACAINE HYDROCHLORIDE, METHYLPREDNISOLONE ACETATE, POVIDONE-IODINE | Asclemed USA, Inc. | 76b15f6a-51d6-45ec-b6cb-8b10a08ed32a | 2026-09-24 | Boxed warning, Warnings, Adverse reactions | 70121-1573-2 70121157302 |
| Methylprednisolone acetate | METHYLPREDNISOLONE ACETATE | Amneal Pharmaceuticals LLC | d944240d-2c19-46ba-ad4f-3fbee7b8629c | 2025-12-15 | Warnings, Adverse reactions | 70121-1573 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.